±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:20 Pharmacological Treatment of Alcoholic Hepatitis Gyongyi Szabo(Harvard Univ. USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:20~09:40 Pharmacological Treatment of Nonalcoholic Steatohepatitis Manal Abdelmalek(Duke Univ. USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:40~10:00 New Horizon of Immuno-Oncologic Therapy Amit Singal(Univ. of Texas Southwestern USA) Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:10 Discussion () ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:05~09:25 Obesity and Alcohol Are Deadly Combination to Induce Steatohepatitis Bin Gao(National Institutes of Health USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:25~09:45 Alcohol-NAFLD Interactions Kenichi Ikejima(Juntendo Univ. Japan) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:45~10:05 Autophagy Regulation in Alcoholic and Non-Alcoholic Liver Steatosis Sang Geon Kim(Seoul National Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:05~10:25 Alcohol-NAFLD Interactions in a Large Korean Cohort Study Yong Kyun Cho(Sungkyunkwan Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:25~10:35 Interaction between CD40L and CD40 Mediates Hepatic Exosomal Delivery to Kupffer Cells in Alcoholic Liver Disease Kyurae Kim(KAIST) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:35~10:45 The Effect of Intestinal Flora Modification on Alcoholic Liver Injury in Obese KK-Ay Mice Kazuyoshi Kon(Juntendo Univ. Japan) Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:45~11:00 Round Table Discussions () ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:20~11:20 Plenary Presentation 1 Kwan Sik Lee Kwan Soo Byun Ho Seong Han(Yonsei Univ Korea Univ Seoul National Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:00~11:20 Neuroendocrine-Fat-Liver Axis Laura E. Nagy(Cleveland Clinic USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:20~11:40 Lymphatic System and Organ Crosstalk Yasuko Iwakiri(Yale Univ. USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:40~12:00 Liver-Lung Crosstalk Gavin E. Arteel(Univ. of Pittsburgh USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:00~12:20 Glutamate/mGluR5-mediated Endocannabinoid in Alcoholic Fatty Liver Won-IL Jeong(KAIST) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:20~12:30 CYP2E1 Regulation of Ethanol-Induced Intestinal miRNAs in Liver Injury Je-Hyun Yoon(Medical Univ. of South Carolina USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:30~12:40 Chronic Alcohol Consumption Alters the Phenotype of F4/80+CD11b+ Bone Marrow Cells by Neuro-Metabolic Signaling Pathway Young-Ri Shim(KAIST) Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:40~13:00 Round Table Discussions () ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:30~12:00 Past, Present, and Future of Precision Hepatology: Where Do We Need to Go? W. Ray Kim(Stanford Univ. USA) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Current Evidences and Future Perspectives for the Treatment of Advanced Hepatocellular Carcinoma Jeong Won Jang(The Catholic Univ. of Korea) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 When Should We Consider Systemic Therapy in BCLC Stage B Hepatocellular Carcinoma? Hyung Joon Yim(Korea Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Therapeutic Efficacy of Transarterial-Based Treatment vs. Targeted Therapy in Advanced Hepatocellular Carcinoma Sadahisa Ogasawara(Chiba Univ. Japan) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:00~14:20 Optimizing Therapeutic Efficacy with Systemic Treatment and Radiotherapy in Hepatocellular Carcinoma Jinsil Seong(Yonsei Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:20~14:30 Discussion () ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:50~14:40 General Oral Presentation 1 (*K) Byung Ik Kim(Sungkyunkwan Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:40~14:55 Current Approaches to the Treatment of Early HCC in Japan Naoshi Nishida(Kindai Univ. Japan) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:55~15:10 Current Approaches to the Treatment of Early HCC in Korea Myeong Jun Song(The Catholic Univ. of Korea) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:10~15:25 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Japanese Experience Do Young Kim(Yonsei Univ) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:25~15:40 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Korean Experience Hee Chul Park(Sungkyunkwan Univ) Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:40~15:50 Discussion () ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:00~16:20 Exploring Unrecognized Risks in Immune Tolerant Phase of Chronic Hepatitis B Young-Suk Lim(Univ. of Ulsan) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:20~16:40 Clonal Hepatocyte Expansion and Hepatitis B Virus Integration Patrick Kennedy(Queen Mary Univ. of London UK) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:40~17:00 Effect of Current and Novel Antivirals on the Prevention of Hepatocellular Carcinoma: Beyond Viral Suppression George V. Papatheodoridis(National and Kapodistrian Univ. of Athens Greece) ±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:00~17:20 Functional Cure of Chronic Hepatitis B and Beyond Man-Fung Yuen(The Univ. of Hong Kong Hong Kong) Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:20~17:30 Discussion ()